<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00367367</url>
  </required_header>
  <id_info>
    <org_study_id>3280105</org_study_id>
    <secondary_id>Ministry of Heath:920050038</secondary_id>
    <secondary_id>Genetics committee: 2005-061</secondary_id>
    <nct_id>NCT00367367</nct_id>
  </id_info>
  <brief_title>Endometrial Curettage Before Embryo Transfer</brief_title>
  <official_title>Endometrial Hysteroscopy and Curettage Prior to Embryo Transfer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Technion, Israel Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <brief_summary>
    <textblock>
      Studies have shown that endometrial sampling in the month prior to embryo transfer may
      increase pregnancy rates. We wish to test this hypothesis by performing a hysteroscopy and
      curettage in the month proceeding embryo transfer during IVF, IVF/ICSI or Frozen/Thawed
      cycles.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It has been suggested that local injury to the endometrium doubles the rate of implantation
      and successful pregnancies in IVF patients.

      Purpose

        1. To determine whether performing curettage the month prior to embryo transfer (ET)
           increases the chance of embryo implantation.

        2. To study molecular attributes of the endometrium taken at curettage and to compare them
           to those cycles resulting in pregnancy and those which do not result in pregnancy.

      Samples will be grown as primary culture in the research laboratory and possible molecular
      markers and attachment assays for endometrial receptivity will be studied.

      Patient selection: Patients undergoing IVF or IVF-ICSI at Ha'Emek medical center/ IVF unit.
      Woman over 35 years of age will be excluded since implantation failure is more likely to be
      due to genetic, chromosomal or cytoplasmic aberrations in their oocytes.

      Proposed protocol:

        1. Informed consent obtained from prospective candidates.

        2. Participants randomly divided to three groups

             1. Control group

             2. Hysteroscopy and curettage performed on days 15-17 of menstrual cycle

             3. Hysteroscopy and curettage performed on days 19-22 of menstrual cycle

        3. After the following menses an IVF, IVF-ICSI, or frozen embryo cycle is performed
           according to the unit's standard protocols.

        4. The primary end point of the study will be the implantation rate after ET and the
           expression of possible molecular markers for endometrial receptivity in the pregnant
           patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2005</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implantation rate</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Pregnancy rate</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Endometrial receptivity</measure>
  </primary_outcome>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Infertility</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hysteroscopy and Curettage</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent

          -  In-vitro fertilization candidate

          -  Normal blood coagulation

        Exclusion Criteria:

          -  Anemia (hemoglobin under 10 mg/dl)

          -  Abnormal maternal karyotype

          -  Thrombocytopenia under 140,000

          -  Any contraindication to hysteroscopy or in-vitro fertilization
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel Geslevich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>haemek medical center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eliezer Shalev</last_name>
    <role>Study Chair</role>
    <affiliation>HaEmek Medicak Center and Technion, Israel Institute of Technology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shlomit Goldman</last_name>
    <role>Study Director</role>
    <affiliation>haemek medical center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amir Weiss, MD</last_name>
    <phone>972-4-6494031</phone>
    <email>weiss_am@clalit.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joel Geslevich, MD</last_name>
    <phone>972-4-6495488</phone>
    <email>yoel_g@clalit.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Obstetrics and gynecology, HaEmek Medical Center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Joel Geslevich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amir Weiss, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shabtai Romano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shlomit Goldman, DSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eliezer Shalev, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <results_reference>
    <citation>La Sala GB, Montanari R, Dessanti L, Cigarini C, Sartori F. The role of diagnostic hysteroscopy and endometrial biopsy in assisted reproductive technologies. Fertil Steril. 1998 Aug;70(2):378-80.</citation>
    <PMID>9696242</PMID>
  </results_reference>
  <results_reference>
    <citation>Barash A, Dekel N, Fieldust S, Segal I, Schechtman E, Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril. 2003 Jun;79(6):1317-22.</citation>
    <PMID>12798877</PMID>
  </results_reference>
  <verification_date>August 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2006</study_first_submitted>
  <study_first_submitted_qc>August 20, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2006</study_first_posted>
  <last_update_submitted>August 20, 2006</last_update_submitted>
  <last_update_submitted_qc>August 20, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2006</last_update_posted>
  <keyword>embryo transfer</keyword>
  <keyword>hysteroscopy</keyword>
  <keyword>curettage</keyword>
  <keyword>iv-vitro fertilization</keyword>
  <keyword>molecular markers</keyword>
  <keyword>endometrial receptivity</keyword>
  <keyword>endometrial dating</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

